In Greek mythology, Scylla was a ferocious beast and Charybdiswas a monstrous whirlpool. The wily Odysseus successfully navigatedbetween these two dangers by steering closer to Scylla, thoughhe did lose a few crew members to her. In a similar manner,the astute clinician managing myocardial ischemia by using antiplatelettherapy attempts to balance coronary thrombosis, the basic causeof myocardial ischemia, against hemorrhage, the most-fearedcomplication of antiplatelet therapy. There are many pathwaysby which antiplatelet drugs may antagonize platelet activationor aggregation, all of which increase the risk of bleeding,and many of which decrease the risk . . . [Full Text of this Article]
Source Information
From the Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland.
This article (10.1056/NEJMe0706859) was published at www.nejm.org on November 4, 2007.
Related Letters:
Prasugrel versus Clopidogrel
Serebruany V., Pasceri V., Patti G., Di Sciascio G., von Lewinski F., Riggert J., Paulus W., Wiviott S. D., Braunwald E., Antman E. M., Bhatt D. L.
Extract |
Full Text |
PDF
N Engl J Med 2008;
358:1298-1301, Mar 20, 2008.
Correspondence
This article has been cited by other articles:
Serebruany, V., Pasceri, V., Patti, G., Di Sciascio, G., von Lewinski, F., Riggert, J., Paulus, W., Wiviott, S. D., Braunwald, E., Antman, E. M., Bhatt, D. L.
(2008). Prasugrel versus clopidogrel.. NEJM
358: 1298-1299
[Full Text]
(2007). Prasugrel in Patients with Acute Coronary Syndromes. JWatch Oncology and Hematology
2007: 1-1
[Full Text]
Previous
